Chen et al (8) demonstrated that attenuation of immune suppression via inhibition of the IDO1 enzymatic activity may be an important mechanism underlying polyphenol-mediated chemoprevention or combinatorial cancer therapy. This evidence concerns the gene IDO1 and cancer.